- Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer
-
Ryu JK
- KMID: 2373330
- Korean J Gastroenterol.
- 2015 Sep;66(3):150-153.
- doi: 10.4166/kjg.2015.66.3.150
Pancreatic adenocarcinoma is one of the fatalist malignancies. A large proportion of patients are diagnosed with unresectable stage pancreatic cancer at the time of presentation. Gemcitabine is a standard chemotherapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
- Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells
-
Hong WS, Kim CM, Lee CT, Lee JO, Kang TW
- KMID: 1421919
- J Korean Med Sci.
- 1992 Sep;7(3):236-240.
- doi: 10.3346/jkms.1992.7.3.236
Recombinant human-interferon-gamma (rH-IFN-gamma) and verapamil (VRP), either alone or in combination, were evaluated in MTT assay for their modification effects on adriamycin-induced cytotoxicity against MKN-45, human stomach adenocarcinoma cells.... -
- CITED
-
- Close
- SHARE
-
- Close
- Astaxanthin Inhibits Proliferation of Human Gastric Cancer Cell Lines by Interrupting Cell Cycle Progression
-
Kim JH, Park JJ, Lee BJ, Joo MK, Chun HJ, Lee SW, Bak YT
- KMID: 2411963
- Gut Liver.
- 2016 May;10(3):369-374.
- doi: 10.5009/gnl15208
BACKGROUND/AIMS: Astaxanthin is a carotenoid pigment that has antioxidant, antitumoral, and anti-inflammatory properties. In this in vitro study, we investigated the mechanism of anticancer effects of astaxanthin in gastric carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
-
Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC
- KMID: 1382660
- Korean J Intern Med.
- 2008 Mar;23(1):37-41.
- doi: 10.3904/kjim.2008.23.1.37
S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
-
Ku JY, Lee JZ, Ha HK
- KMID: 2344111
- Korean J Urol.
- 2015 Oct;56(10):689-694.
- doi: 10.4111/kju.2015.56.10.689
PURPOSE: To investigate the efficacy of androgen deprivation treatment (ADT) between continuous and intermittent ADT. MATERIALS AND METHODS: Between January 2006 and May 2015, 603 patients were selected and divided into... -
- CITED
-
- Close
- SHARE
-
- Close
